Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
b-cell lymphoblastic leukemia/lymphoma, car-t, dual-target, relapsed / refractory b cell hematological tumors, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1044888
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.